Gollamudi R - Search Results

1

Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.

Gollamudi R, Ghalib MH, Desai KK, Chaudhary I, Wong B, Einstein M, Coffey M, Gill GM, Mettinger K, Mariadason JM, Mani S, Goel S. Gollamudi R, et al. Invest New Drugs. 2010 Oct;28(5):641-9. doi: 10.1007/s10637-009-9279-8. Epub 2009 Jul 2. Invest New Drugs. 2010. PMID: 19572105 Free PMC article. Clinical Trial.

2

Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers.

Goel S, Desai K, Karri S, Gollamudi R, Chaudhary I, Bulgaru A, Kaubisch A, Goldberg G, Einstein M, Camacho F, Baker S, Mani S. Goel S, et al. Among authors: gollamudi r. Invest New Drugs. 2007 Jun;25(3):237-45. doi: 10.1007/s10637-006-9028-1. Epub 2006 Dec 30. Invest New Drugs. 2007. PMID: 17195945 Clinical Trial.

3

Novel orphan nuclear receptors-coregulator interactions controlling anti-cancer drug metabolism.

Gollamudi R, Gupta D, Goel S, Mani S. Gollamudi R, et al. Curr Drug Metab. 2008 Sep;9(7):611-3. doi: 10.2174/138920008785821701. Curr Drug Metab. 2008. PMID: 18781912 Review.

4

New carbamoylpiperidines as human platelet aggregation inhibitors.

Guo Z, Zheng X, Thompson W, Dugdale M, Gollamudi R. Guo Z, et al. Among authors: gollamudi r. Bioorg Med Chem. 2000 May;8(5):1041-58. doi: 10.1016/s0968-0896(00)00033-x. Bioorg Med Chem. 2000. PMID: 10882016

5

Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.

Han G, Bannerman D, Handa RK, Dillingham EO, Lawrence WH, Gollamudi R. Han G, et al. Among authors: gollamudi r. Gen Pharmacol. 1997 Apr;28(4):617-21. doi: 10.1016/s0306-3623(96)00272-8. Gen Pharmacol. 1997. PMID: 9147034

6

Antiplatelet agents affecting the interaction of Tissue Factor-Factor VIIa complex with Factor X in a continuous-flow reactor.

Gir S, Reavis R, Turitto VT, Gollamudi R. Gir S, et al. Among authors: gollamudi r. Biotechnol Appl Biochem. 1996 Feb;23(1):63-6. Biotechnol Appl Biochem. 1996. PMID: 8867897

7

Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.

Herron D, Dillingham EO, Lyman BA, Zheng X, Bond SE, Salgia SR, Gollamudi R. Herron D, et al. Among authors: gollamudi r. Prostaglandins Leukot Essent Fatty Acids. 1995 May;52(5):309-18. doi: 10.1016/0952-3278(95)90032-2. Prostaglandins Leukot Essent Fatty Acids. 1995. PMID: 7630919

8

Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors.

Zheng X, Salgia SR, Thompson WB, Dillingham EO, Bond SE, Feng Z, Prasad KR, Gollamudi R. Zheng X, et al. Among authors: gollamudi r. J Med Chem. 1995 Jan 6;38(1):180-8. doi: 10.1021/jm00001a023. J Med Chem. 1995. PMID: 7837229

9

Synthesis of stereoisomers of antithrombotic nipecotamides.

Zheng X, Day C, Gollamudi R. Zheng X, et al. Among authors: gollamudi r. Chirality. 1995;7(2):90-5. doi: 10.1002/chir.530070207. Chirality. 1995. PMID: 7742174

10

Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets.

Handa RK, Dillingham EO, Gollamudi R. Handa RK, et al. Among authors: gollamudi r. Life Sci. 1995;57(10):983-8. doi: 10.1016/0024-3205(95)02033-f. Life Sci. 1995. PMID: 7643723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters